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Abstract:
Background: Smoking rates in Appalachian counties are about two times higher than in
non- Appalachian counties. Apart from the detrimental effects smoking has on the smoker,
exposure to second-hand smoke (SHS) can have negative health effects on both adults and
children. SHS exposure can result in asthma exacerbations and other respiratory difficulties,
impaired neuromotor function, neurobehavioral problems, and decreased performance in school.
Objective: The objective of this study was to determine whether SHS exposure, as
measured by serum cotinine, is associated with learning and memory in children, as measured by
the California Verbal Learning Test – Children's Version.
Methods: Children 7–9 years of age were enrolled in the Communities Actively
Researching Exposure Study (CARES) from Marietta, Cambridge, and East Liverpool, Ohio,
and their surrounding communities (N = 510). Manganese and lead levels were collected from
blood, and cotinine was extracted from serum. Correlations between these biomarkers were
obtained. A backward elimination multivariate analyses was performed for each of the learning
and memory outcomes. Explanatory variables that were significant at the 0.1 level were kept in
the model.
Results: Geometric means of the biomarkers of environmental exposure cotinine,
manganese, and lead were 0.12 ± 8.1 ng/mL. After model selection, the logarithmic
transformation of serum cotinine was significantly associated with lower scores for total learning
(β= -0.077, p-value = 0.005) and short-delayed recall of list A (β= -0.077, p-value = 0.005).
Conclusion: Higher serum cotinine was associated with deficits in learning and memory
performance. Multiple exposures were included in the study, therefore, these results cannot be

associated solely with serum cotinine. To further prove these findings, addition studies need to
be conducted.

Introduction
According to the World Health Organization (WHO) nearly 1.3 billion people worldwide
use tobacco products and about 7 million die of diseases associated with tobacco smoke each
year. Tobacco use has long been considered one of the major health threats in the United States
(CDC) In the United States, it is responsible for more than 480,000 deaths per year including
41,000 deaths that result from secondhand exposure (Smoking & Tobacco Use, CDC). It is the
most prevalent cause of mortality and the most significant risk factor for different types of cancer
(Hwang et al, 2012). Tobacco smoke contains over 3,000 toxic chemicals, including polycyclic
aromatic hydrocarbons, lead, cyanide, and other carcinogens like nicotine and carbon monoxide
(Florescu et al, 2009). Strong clinical and epidemiological evidence associates smoking with
diseases of the circulatory and respiratory systems; however, the association of smoking with
diseases that affect the nervous system and the brain are not as well understood (Chang et al,
2014).
Environmental tobacco smoke (ETS) or secondhand smoke (SHS) refers to the inhaled
tobacco smoke produced or exhaled by an active smoker and the smoke released from the
burning end of the cigarette (Florescu et al, 2009). This passive exposure to tobacco smoke
contributes significantly to morbidity and mortality in children as well as adults. Children,
however, are the population that is the most susceptible to the adverse effects of ETS (Cheraghi
et al, 2009). Children are exposed to SHS in different environments like homes, schools,
restaurants and other public places, and often do not have the ability to choose not be in those
places. Although children may be exposed to other pollutants, household tobacco smoke is the
most common air pollutant inside homes and can lead to significant maternal and fetal exposure
that ultimately result in numerous harmful effects (Seong et al, 2008).

Generally, children are at higher risk for adverse health effects resulting from exposure to
environmental toxins and chemicals because on a kilogram per kilogram basis, children drink
more fluids, breathe in more air, eat more food than adults and have increased metabolic rates
(Canfield et al, 2005, Landrigan & Carlson, 1995). Therefore, a child is likely to accumulate
more toxins than an adult who is exposed to the same levels of environmental toxins. For
example, children inhale more SHS, and the effects of SHS exposure are exacerbated by the
reduction in expiratory flow in children exposed to SHS (Martinez et al. 1988). Mannino et al.
found a strong association between higher serum cotinine levels and worse lung function among
5400 children aged 8 to 16 years (2001).
Children also have immature adaptive immune systems and thus are not able to detoxify
their bodies of harmful substances as well as adults (Ginsberg, 2002). According to Dempsy et
al., neonates and younger children have diminished nicotine metabolism, as indicated by nicotine
half-life that is three to four times longer in newborns and children exposed to SHS than in adults
(2000). Cotinine, however, has a similar half-life in children and adults (Leong et al., 1998).
Children also tend to be physically close to their parents or caregivers, thus increasing their
chances of inhaling SHS (Hwang et al, 2012).
Consistent evidence has shown an association between exposure to SHS and outcomes
like preterm birth, asthma exacerbations and other respiratory difficulties (Chilmonczyk et al.
1993; Ehrlich et al. 1996; Martinez et al. 1992; Gergen et al. 1998; Mannino et al. 2001;
Martinez et al. 1988; Rylander et al. 1995), sudden infant death syndrome (McMartin et al. 2002;
Wisborg et al. 2000), impaired neuromotor functions (Yermanin et al., 2015), and
neurobehavioral problems and decreased performance in school (Yolton et al, 2005; Julvez et al,
2007)

Although many studies have identified an association between neurocognitive outcomes
and SHS, there is little evidence on the effects of SHS on memory performance in children.
Yolton et al., studied 4399 National Health and Nutrition Examination Survey (NHANES)
participants ages 6-16 and found that serum cotinine was significantly associated with lower
scores for reading, math, and visuospatial skills (2005). Another study by Lee at al., in Seoul,
South Korea found that 414 children who were 6 months old and who were exposed to
secondhand smoke had a Mental Developmental Index (MDL) of the Bailey Scale of Infant
Development score 2.8 points lower than children who were not exposed to secondhand smoke
(2011). Neither of these studies measured the effects of this exposure on memory.
Our study focused on a cohort of children ages 7-9 who reside in the Appalachian
communities of Marietta, Cambridge or East Liverpool, Ohio and are participants in the
Communities Actively Researching Exposure Study (CARES) (Haynes et al, 2015). Exposures
to neurotoxins like SHS, lead and manganese were recorded, and a series of developmental,
motor and cognitive outcomes were measured for each child, with consent from the
mother/caregiver. The objective of the current study was to determine if exposure to secondhand
smoke, as measured by serum cotinine, decreases memory performance and learning, as
measured by the California Verbal Learning Test – Children’s version (CVLT-C).

Literature Review
Different forms of Second-Hand Tobacco Smoke (SHS)
In SHS, most of the nicotine leaves the particulate phase and transforms into a gaseous or
vapor phase allowing it to be breathed in by the nose and throat and inhaled into the lungs. SHS

is categorized based on the source of smoke (Benozitz, 1996). Mainstream smoke refers to the
smoke that is inhaled or taken in by the smoker and then released into the environment. Side
stream smoke refers to the smoke emitted from the burning end of a cigarette (Moir et al, 2007).
Side stream smoke has been estimated to account for more than 75 percent of the nicotine
released into the air (Benowitz, 1996). Side stream smoke consists of particles that are
significantly smaller than that of mainstream smoke thus making it more likely to penetrate the
airways of children (Neal et al, 2005).
Cotinine as a measure of SHS
Self-report of extent of exposure to SHS is likely to be an imprecise indicator of true
tobacco smoke intake (Benowitz et al, 1991). This is due to the variation in the number and type
of cigarettes smoked, the proximity of the smoker to the nonsmoker, the environmental
characteristics like ventilation and space, and individual differences in sensitivity to SHS
(Benowitz, 1996). Also, the optimal assessment of exposure to SHS is the measurement and
analysis of smoke constituents in the bodily fluids of the exposed individual (i.e., biomarkers like
saliva, blood, and hair) (Benowitz, 1996).
Nicotine and other chemicals in SHS decay at different rates and therefore, the ratio of
nicotine to the other constituents in SHS differs over time (Nelson et al, 1996; Eatough et al,
1989; Rando et al, 1992) The same can be said for the metabolism of nicotine and other
chemicals in the body. When nicotine is inhaled into the lungs, it enters the bloodstream and is
then circulated to other organs in the body, including the liver where it is metabolized. Of the
inhaled nicotine, only about 5-10 percent is excreted unchanged in the urine (Benowitz et al,
1994). According to Benowitz, about 70-80 percent of nicotine gets converted to cotinine, on
average. Nicotine has a very short half-life, 2-3 hours, making it hard to estimate exposure.

Cotinine, on the other hand, has a longer half-life, about 17 hours, and tends to build up
throughout the day and remain relatively stable over time (Benowitz, 1996). Therefore, cotinine
has been the preferred measure used to estimate nicotine exposure from tobacco.
As mentioned previously, cotinine levels can be measured in blood, urine, saliva, and
hair. Hair cotinine measured provides an index of cumulative exposure over time (Eliopoulus et
al 1994 & Mafstad et al. 1995). Because nicotine is metabolized in the liver and released into the
bloodstream, blood levels of cotinine more accurately represent the dose of nicotine absorbed
from ETS (Benowitz, 1996) Most studies of SHS exposure have used urine or saliva
concentrations of cotinine simply because those samples are easier and cheaper to collect.
However, according to Benowitz, saliva and blood cotinine are highly correlated.
Low Level Lead Exposure and Cognitive Function
Lead is a naturally occurring element that was previously used as a gasoline additive and
as a pigment for paints and glazes among other products. Its usefulness led to its widespread
distribution, making it one of the most prevalent toxic metals in the environment (Canfield,
2005). Infants and young children are at particularly high risk of exposure because they
frequently engage in hand-to-mouth behavior (Barbara et al, 2018). According to the Agency for
Toxic Substances and Disease Registry (ATSDR), ingestion and/or inhaled lead is not
metabolized in the body. Rather, it is first absorbed into the bloodstream and then eventually gets
stored in soft tissue, bone and teeth (Agency for Toxic Substances and Disease Registry).
According to the Centers for Disease Control and Prevention (CDC), high blood lead
levels (BPb) – 100 µg/dL - result in severe and obvious symptoms like irritability, attention
difficulty, memory loss, comas and even death within weeks of exposure. Children may display
these symptoms at even lower levels of exposure (Canfield, 2005). A cohort study in Boston

focusing on a cohort of children with BPb below 10 µg/dL showed that a 10 µg/dL increase in
BPb measured at age 2 was associated with a 5.8-point deficit in the intelligence test score
(Bellinger et al, 1992). Schwartz et al, conducted a threshold analysis on the Boston cohort data
and found no support for the presence of a threshold below which there were no neurobehavioral
effects, at least down to 1 μg/dL of BPb (1995). A cross-sectional study of more than 5000
children ages 6-17 who participated in NHANES III were reported to have lower cognitive
performance as a function of increasing BPb at levels as low as 5 µg/dL; these children also had
poorer short-term memory (Lanphear et al, 2000).
Memory performance in children has not been as extensively studied as intellectual
impairments resulting from lead exposure; a few studies have, however, demonstrated that
memory performance is diminished in those exposed to low levels of lead. A group of 534
children ages 6-11 with BPb levels of 5-10 μg/dL were found to have decreased attention and
working memory compared to children who had levels of 1-2 μg/dL (Surkan et al, 2007).
Another group of 1341 Chinese children ages 3-5 years with mean blood lead concentration was
6.43 µg/dL were found to cognitive deficits as well as decreased verbal working memory (Liu et
al, 2013).
A case-control study comparing 31 lead-exposed workers and 34 control individuals
reported a significant difference in working memory performance between the two groups;
although the fact that the exposed workers were less educated than the controls is important to
note (Seo et al, 2014). Higher calcaneal (bone) lead levels were also associated with increased
memory impairment in a pilot study of 47 healthy subjects 55-67 years of age. Decreased
memory performance has been observed in older and younger adults exposed to lead (Khalil et
al, 2009 & Stewart et al, 2007). Lead-exposed adults have shown decreased performance on both

verbal memory - including worsened immediate recall, delayed recall, and recognition - and
visual memory tasks (Schwartz et al, 2000).
Manganese Exposure and Cognitive Function
Manganese (Mn) is an essential trace element required for adequate growth and the
development, regulation and function of numerous organ systems and is present in virtually
every diet in low concentrations (Aschner & Aschner, 2005). Ingestion is the primary route of
Mn exposure, and ingested Mn levels are under tight homeostatic control (Papavasiliou et al.
1966). Inhalation exposure can also occur; however, inhaled Mn can be diffused and transported
through the blood-brain barrier and can potentially disrupt the homeostatic levels of Mn and
result in overexposure (Haynes et al, 2015).
Overexposure to Mn has been associated with different neurocognitive and motor
functions (Hernández-Bonilla et al. 2011; Long et al. 2014; Lucchini et al. 2012). In fact, Clause
Henn et al, reported an inverse U- shaped association between Mn and Mental Developmental
Index within the Bayley Scale of Infant Development suggesting that both low and high levels
on Mn could potentially lead to adverse neurodevelopmental effects (2010). Mn has also been
associated with memory performance in children. A study conducted in Mexico assessed the
effect of Mn exposure on verbal memory and learning in 79 children ages 7- to 11 years who live
in a Mn mining district; when compared to 95 unexposed children, those who had elevated BMn
had diminished long-term memory and learning abilities (Torress-Augustin et al, 2013)
A study in Bangladesh measured the effects of Mn in drinking water on different
neurocognitive outcomes, including memory, in a group of 303 children ages 9 and 10. Poorer
working memory performance was significantly associated with higher Mn exposure
(Wesserman et al, 2014). Another study also looked at the effects of Mn in drinking water on

CVLT-C memory scores in 375 Canadian children 6-13 years of age. The scores for memory
tended to be lower for higher Mn intake, with a difference of –0.4 points (95% CI: –0.9, 0.1; p =
0.13) for a 10-fold increase in Mn intake from water ingestion (Oulhote et al, 2014).

Methods
Data used in this study were drawn from the Communities Actively Researching Expose
Study (CARES) (Haynes et al, 2015). Marrietta, Ohio, one of the three communities
participating in the cohort study, is home to the longest-running ferromanganese refinery in
North America. The aim of the CARES study was to address the community’s leading
environmental public health concern, which was “Does Mn affect cognitive development of
children?” (Haynes et al. 2011). The study population consists of 7-9 year old children who
resided in Marietta, Cambrisge or East Liverpool throughout life (Rugless et al. 2014). Children
were eligible if their families had no plans of moving within the next year and if their biological
mother resided in the catchment area during her pregnancy with the index child (Haynes et al,
2015). Children who had health conditions, like significant visual, auditory or motor
impairments, that affected their ability to participate were excluded from the study. All parents of
the children included in this study provided consent. This study was approved by the University
of Cincinnati's Institutional Review Board. Study participants were enrolled from 2009 through
2013 (Yeremanini, 2016)
Measurements of SHS and other biomarkers of environmental exposure
As described by Haynes et al, and Yeramanini et al, serum cotinine levels were measured
by the by the New York State Department of Health’s Wadsworth Center, using a high-

throughput 96-well plate format sample preparation, and then analyzed using an isotope dilution,
liquid chromatography/tandem mass spectrometry method (Haynes et al, 2015 & Yeramanini et
al, 2016) This method of serum cotinine collection is a modification of the techniques used by
the Centers for Disease Control and CDC for the NHANES study and the New York State
Wadsworth Laboratory for the NYC Health and Nutrition Examination Survey studies (Bernert
et al. 1997, Ellis et al. 2009, Haynes et al, 2015, Yeramaninin et al 2016).
Each serum specimen was first equilibrated with a trideuterated cotinine internal standard
solution then extracted using a 96-well Bond Elut Plexa solid-phase extraction (SPE) plate
(Varian, Palo Alto, California). The acetonitrile (CH 3 CN) sample extract was first taken to
dryness, then reconstituted in 96%/4% acetonitrile/water solution and finally analyzed by liquid
chromatography/tandem mass spectrometry (LC/MS/MS) using electrospray ionization. The
instrument system included a Shimadzu Prominence LC (Shimadzu Corp, Tokyo, Japan) with a
Phenomenex Luna HILIC (100 × 2.00 mm) column and AB Sciex API 4000 triple quadrupole
mass spectrometer operated in electrospray ionization positive ion mode using multiple reaction
monitoring (MRM) detection. Low, medium, and high target cotinine concentrations of 0.173,
1.61, and 15.7 ng/mL, respectively were used as quality control pools. The method detection
limit for this technique was 0.05 ng/ mL cotinine in serum which was subsequently used to
determine those who had been exposed to SHS. Of the samples in this study, over 50% of t he
samples were below the method of detection limit, however, the laboratory provided values for
those samples and those values were included in the statistical analyses (Haynes et al, 2015;
Yeramanini et al, 2015)
Blood samples were analyzed for Mn using graphite furnace atomic absorption
spectrometry (GFAAS) equipped with a transversely heated graphite atomizer and a longitudinal

Zeeman background correction system using previously described method and quality-control
measures (Praamsma et al. 2012). The method detection limit for Mn in blood using this
technique was 1.5 μg/L.
Blood Pb (BPb) was determined by inductively coupled plasma mass spectrometry (ICPMS) (Haynes et al. 2015) utilizing a method optimized and validated for biomonitoring purposes
as described elsewhere (Birdsall et al. 2010; McKelvey et al. 2007). A PerkinElmer® Sciex
ELAN DRC Plus ICP-MS instrument equipped with a Burgener Teflon MiraMist® nebulizer
(Burgener Research Inc., Mississauga, ON, Canada) and a Cinnabar spray chamber (Glass
Expansion, West Melbourne, VIC, Australia) and operated in standard mode was used for all
BPb measurements. The limit of detection for BPb using this method was 0.04 μg/dL.
California Verbal Learning Test
The California Verbal Learning Test – Children’s Version (CVLT-C) is a word list
learning instrument used by clinical neuropsychologists in North America (Woods et al., 2006).
The CVLT- C provides a relatively short, individually administered assessment of the cognitive
processes involved in learning and recalling verbal information. The test is validated for children
between 5-16 years of age and is meant to help professionals diagnose and treat memory
impairments and mild to severe learning disabilities.
The CVLT-C consists of a “Monday Grocery List” (list A) and an interference list
“Tuesday Grocery List” (list B), each of which has 15 words. In the first five trials, the child is
read the words from list A at the beginning of each trial and is asked to recall as many words
from the list as possible. The interference list (list B) is then presented for one trial, and the child
is asked to recall as many words as possible from list B. Following the interference trial, the

child is asked to remember as many words as possible from list A, but the list is not presented to
the child again.
The number of words acquired in the first five trials are summed and referred to as the
“total learning score.” The raw total learning score is also converted to a standardized score,
called a T score. The learning slope represents a measure of how fast the child learned items at
each successive learning trial. A negative learning slope indicates that the child remembers less
words as the trials continue. The learning slope is standardized and provided as a Z score. The
number of words recalled from list A after the interference list is read, is referred to as “short
delayed recall” and is also converted into a Z score. The items recalled from List B represent
immediate recall – List B is read once and the child is asked to remember as many words as they
can from that list.
Covariates
The covariates and confounders that have been reported to influence the association
between exposure to SHS and memory performance were also measured. General demographic
factors, including the child’s age (in years), sex, and race were obtained, along with
characteristics of the child’s parents, including prenatal smoking (yes/no), parent education level
and parent IQ from the Wechsler Abbreviated Scale of Intelligence. Biomarkers of heavy metal
exposure like blood lead and blood manganese levels, which are known to have adverse
associations with cognition were analyzed.
Statistical Analysis
Descriptive statistics were used to describe and inspect the data for incomplete
information and distributional properties. Demographic characteristics of the children and their

parents, as well as biomarkers of environmental exposure, are presented as means and standard
deviations for continuous variables and as frequencies and percentages for categorical variables.
The data values of the biomarkers - serum cotinine, blood lead and blood manganese - were
logarithmically transformed to obtain the geometric mean of the values, due to the skewed
distribution of the values. Multivariable linear regression modeling was used to identify
significant variables at an a priori α value of 0.05.
The first phase of the linear regression analysis included bivariate analyses between the
memory and learning CVLT-C outcome measures and the exposure of interest – serum cotinine as well as the other covariates. Variables that had an association with the outcome at p < 0.25
were included in the initial multivariable model. A modified backward elimination procedure
with a significance level of 0.1 was performed for each multivariable model. If a > 10% change
was observed in the regression estimate of serum cotinine, it was considered a confounder and
was retained in the model regardless of statistical significance.
Results
A total of 510 children were included in the study. Descriptive statistics of the children
and their parents as well as measures of environmental exposures are presented in Table 1. The
majority of the cohort consisted of Caucasian – non-Hispanic white - children (93%). Most of the
parents (89.6%) had at least some college education and were not smokers (69%). The children
without detectable serum cotinine levels (n =112 or 22%) were compared to the children with
available cotinine levels. There was no significant difference between the children on
demographic factors like race, gender, age at testing, and parents’ IQ, thus these children were
not included in the analyses reducing the original sample size to N = 398.

SHS exposure was determined by a cotinine biomarker level ≥ 0.05 ng/mL or by ≥ 1
cigarette smoked in the household per day. About 44.1% of the children were considered
exposed to secondhand smoke and had serum cotinine levels above 0.05 ng/mL. Prenatal
exposure to smoke was not included in the analyses, however, 23.1% of the mothers reported
smoking during pregnancy. Over 28% of the children were exposed to a number of cigarettes
greater than the mean among all families (9.4 cigarettes/household/day). Geometric means of the
biomarkers of environmental exposure cotinine, manganese, and lead were 0.12 ± 8.1 ng/mL,
9.67 ± 1.27 µg/ L, 0.86 ± 1.65 µg/dL respectively. Correlations among the biomarkers, shown in
Table 2, were statistically significant between serum cotinine and BPb levels (r = 0.41,
p<0.0001) and BMn and BPb (r = -0.12, p=0.014).
In the bivariate analyses, shown in Table 3, there was a statistically significant
association between the logarithmic transformation of serum cotinine and three measures of the
learning and memory on the CVLT-C. The learning slope was the only measure that was not
significantly associated with serum cotinine (β = -0.031, p-value= 0.23). Total learning (β = 0.933, p<0.0001), list A short-delay (β = -0.080, p=0.0004) recall and immediate recall of List B
(β = -0.051, p=0.026) were all significantly associated with serum cotinine. Among the
environmental neurotoxicants included in this study, there was a significant association only
between lead and total learning (p=0.0046) and Immediate recall of List B (p= 0.027). Mn was
not found to be significantly associated with the any of the CVLT-C measures.
Both BPb and BMn were not associated with the outcome at the univariate level and thus
were not included in the multivariate models. Multivariable analyses revealed that when
accounting for the child’s age, gender, socioeconomic status, and mother’s IQ, the logarithmic
transformation of serum cotinine was independently and significantly associated with lower

scores for total learning (β= -0.65, p=0.0078), but the magnitude of the association was quite
diminished. Short-delayed recall (list A) was also independently and significantly associated
with serum cotinine (β= -0.071, p = 0.0013). Finally, immediate recall of List B was also
associated with serum cotinine even when age and sex of the child were included in the model.

Discussion
Results from this cross-sectional study examining the relationship between exposure to
SHS and learning and memory, showed that higher exposure to SHS was significantly associated
with lower memory performance and learning. In the unadjusted analyses, SHS exposure was
associated a decrease in total learning of list A and poorer d elayed recall of list A and immediate
recall of list B. After adjusting for other covariates like age, gender and mother’s IQ, higher
exposure to SHS was still significantly associated with total learning and delayed recall of list A.
The results from the multivariate analyses indicate that the total learning T score decreases by
0.77 points for every 1-unit increase in the log of serum cotinine. Although these findings may
indicate a low clinical significance, they are important to note. In the study by Yolton, results
showed a significant inverse relationship between serum cotinine and scores on reading (β= –2.69, p=
0.001) and math (β = –1.93, p= 0.01) tests in children ages 6-16; these results are important
because these effects were found at “lower levels of secondhand smoke exposure” – serum
cotinine levels at or below 15 ng/dL.
The majority of the literature studying the effects of SHS on neurocognition in children
have focused primarily on school performance and academic achievement (Makin et al, 1991;
Bauman et al, 1989; Yolton et al, 2005), changes in IQ (Breslau et al. 2005; Cho et al, 2010) and

neurodevelopment (Lee et al, 2011; Julvez et al. 2007). The literature that has focused on the
association of SHS with memory and learning mostly include older individuals and adolescents,
not children. In this study, our major focus was to understand and explore the relationship
between tobacco smoke exposure, as measured by serum cotinine levels, and learning and
memory in children ages 7-9. These findings are consistent with those of Julvez et al, who found
a negative association with working memory in 4-year old children who were born to smoking
mothers and were exposed to SHS after birth (Julvez et al, 2007).
It is important to note that although the literature is lacking in the area specific to memory
in children exposed to SHS, multiple studies have found a significant relationship between SHS
and memory in older adults. A study comparing prospective memory among smokers, nonsmokers exposed to SHS, and non-smokers not exposed to SHS, reported that the group with no
exposure to SHS recalled significantly more time-based tasks (means= 16.3 vurses 13.7, pvalue=<0.001) than both the smoking group and the group exposed to SHS, even after adjusting
for important covariates (Heffernan and O’Neill, 2012). Another study examined the doseresponse relationship between SHS exposure and dementia syndromes in a Chinese population.
Their results showed a significantly increased risk of severe dementia syndromes in individuals
with higher levels of SHS exposure and who had been exposed for longer periods of time (Chen
et al, 2012). Children who are born to smoking mothers has smaller head circumference
compared to children born to non-smoking mothers. Also, according to Friedrich, never smokers
who resided with smokers for more than 10 years showed a 30% increase in risk for dementia
(2007).
According to Chang,

The difference in memory between males and females is also important to note. In the
analyses, females were considered the reference group. As shown in table 4, the estimate for
gender is negative for each outcome variable where gender remained in the model, meaning male
children had lower scores. These results are consistent with other studies that have studied the
effect of gender on memory (Rabbitt et al, 1995 & Herlitz et al, 1999). According to Kramer et
al, women generally perform better than men in virtually every type of verbal memory task
(2003). These differences have been consistent throughout different age groups (Kramer et al,
1997).
The children included in this study resided near the longest running ferromanganese
refinery in North America, thus biomarkers for manganese and lead exposure were included in
the initial analyses. Although previous studies have clearly established associations between
other neurotoxicants and memory, we did not observe a significant relationship between the
measures of learning and memory and measured neurotoxicants - manganese and lead
(Hernández-Bonilla et al. 2011; Long et al. 2014; Lucchini et al. 2012; Surkan et al, 2007). The
association between the outcome and lead and manganese as predictor variables were
insignificant in both univariate and multivariate analyses. Although our results showed a lack of
association, it was important to include these environmental exposures in the initial analyses to
rule out any confounding they may cause (Bellinger, 2004).
Some strengths of this paper also include using serum cotinine as the measure of secondhand smoke exposure; this offsets the limitation of using subjective self-reported information on
the child’s exposure which may be biased or inaccurate. The inclusion of covariates that have a
known effect on neurocognitive outcomes, like environmental exposure to toxicants, quality of
household environment, and parental cognitive abilities are also a major strength of this study.

Also, regardless of the limit of detection for the biomarkers, the testing laboratory was able to
provide biomarker levels that were below the limit of detection, which strengthened the analyses.
Finally, this study is the first on this topic to be done in an exclusively Appalachian study
population.

This study has some limitations. This study has a cross-sectional design, which limits
interpretations of the results as associational and not causal. Another limitation is that although
serum cotinine levels were obtained, specific information on duration of the child’s exposure to
SHS and the location of the child relative to the smoker was not obtained. Self -reports on the
number of cigarettes smoked in the household per day may also be subject to bias. Although,
mothers were asked about their smoking habits while pregnant with the index child, the analyses
did not distinguish the effects of prenatal smoke exposure from childhood second -hand smoke
exposure on the outcome; thus, prenatal smoke exposure was not included in the analyses. This
may have resulted in residual confounding.
The results from this study suggest that exposure to SHS is associated with a decline in
learning and memory performance; however, because multiple exposures may exist and their
effect on cognition cannot be ignored. The findings in this study that suggest the adverse role of
SHS on memory performance include: (1) the significant negative associations observed between
serum cotinine levels and the CVLT-C outcome measures, even after adjusting for other
potential explanatory variables, (2) the lack of a significant association between serum cotinine
and the other neurotoxicants – blood lead and blood manganese (3) the use of serum cotinine
levels as a measure of SHS exposure, thus reducing bias. In conclusion, the results from this
study indicate that exposure to SHS plays an important role in the neurodevelopment of children.

The children who have been exposed to SHS had lower memory performance and decreased
learning. Additional research is needed to confirm these findings. It is also important to note that
genetic, social and environmental factors can all have significant effects of cognitive
performance in children and therefore, it remains challenging to determine the role of exposure
to tobacco smoke during pregnancy and after.

Appendix:

Table 1: Demographic characteristic of the CARES cohort
Characteristic
N
Child Characteristics
Age at test (Mean ± SD)
510
Sex: n (%)
508
Females
Males
Race: n (%)
508
Caucasian
Black
Other
Biomarker (Geometric Mean ± Geometric SD)

Summary

Serum Cotinine (μg/L)

398

0.12 ± 8.1

Blood Manganese (μg/L)

393

9.67 ± 1.27

Blood Lead (μg/dL)

394

0.86 ± 1.65

Parents Measures
Parent IQ (Mean ± SD)

508

102.99 ± 13.37

Barratt’s Education (Mean ± SD)

508

14.15 ± 2.82

Parent Education: n (%)
High school education or less
Any college education
Postgraduate
Parents self-reported smoking n (%)
Yes
No
Prenatal Smoking n (%)
Yes
No
Don’t know
Total Cigarettes Smoked/day/
household (Mean ± SD)

504

8.37 ± 0.92
252 (49.61 %)
256 (50.39 %)
473 (92.75 %)
11 (2.16 %)
24 (5.09 %)

150 (29.77 %)
302 (59.92 %)
52 (10.32 %)
493
193 (39%)
300 (61%)
493
114 (23.12 %)
378 (76.67 %)
1 (0.2 %)
9.39 ± 14.36

Table 2: Bivariate association between serum cotinine, blood lead (BPb) and blood manganese (BMn)
and children’s memory and learning – Correlation coefficient, p-value, number of observations

Serum
Cotinine

BMn

BPb

Learning Total
Slope
Learning

Shortdelay
recall

Immediate
recall (List B)

Serum
Cotinine
BMn

-0.05067
0.3176
391

BPb

0.41382
<.0001
392

-0.12328
0.0145
393

Learning
Slope

-0.05884
0.2422
397

-0.02694
0.5944
393

-0.06149
0.2233
394

Total
Learning

-0.20765
<.0001
397

0.00068
0.9893
393

-0.14241
0.0046
394

0.41471
<.0001
506

Short-delay
recall

-0.17780
0.0004
397

0.08438
0.0948
393

-0.06475
0.1997
394

0.44508
<.0001
506

0.65420
<.0001
506

Immediate
-0.11171
recall (List B) 0.0260
397

0.05389
0.2866
393

-0.11086
0.0278
394

0.05775
0.1946
506

0.36766
<.0001
506

0.28171
<.0001
506

Table 3: Univariate linear regression models with cotinine as the only predictor variable

Learning and Memory
Outcomes
Learning Slope (List A)_
Total Learning (List A)
Short-delay recall (List A)

β

P-value

-0.031
-0.933
-0.080

0.24
<0.0001
0.0004

Immediate recall (List B)

-0.051

0.026

Table 4: Multivariate linear regression models
Learning and
Memory Outcomes

Explanatory
Variables

β

P-value

Adjusted R2

Learning slope

Serum Cotinine

-0.032

0.233

0.003

Total Learning

Serum Cotinine
Age at test
M vs F
Mom’s IQ

-0.65 (-1.09 to -0.16)
2.03 (1.07 to 3.08)
-2.79 (-4.57 to -0.92)
0.063 (-0.006 to 0.13)

0.0078
0.0001
0.0032
0.092

0.05

Short-Delay recall

Serum Cotinine
Age at test
M vs F

-0.071 (-0.12 to -0.64)
0.160 (0.067 to 0.29)
-0.233 (-0.43 to -0.06)

0.0013
0.0021
0.0135

0.07

Immediate recall
(List B)

Serum Cotinine
Age at test
M vs F

-0.045 (-2.3 to -0.51)
0.139 (0.04 to 0.25)
-0.290 (-0.49 to -0.11)

0.048
0.009
0.003

0.06

-

Variables included in the backward elimination: serum cotinine, age, sex, caregiver IQ,
parent education and parental smoking

References:
1. Lockman PR, Van der Schyf CJ, Abbruscato TL, Allan DD. Chronic nicotine exposure
alters blood-brain barrier permeability and diminishes brain uptake of
methyllycaconitine. Journal of Neurochemistry, 2005, 94, 37-44.
2. Florescu A, Ferrence R, Einarson T, Selby P, Soldin O, Koren G. Methods for
Quantification of Exposure to Cigarette Smkoing and Enviromental Tobacco Smoke:
Focus on Developmental Toxicology. The Drug Monit. 2009, 31(10): 14-30.
3. Hwang SH, Hwang JH, Moon JS, Lee DH. Environmental tobacco smoke and children's
health. Korean J Pediatr. 2012;55(2):35–41. doi:10.3345/kjp.2012.55.2.35
4. Chang RC, Ho YS, Wong, S, Gentleman SM, Ng HK. Neuropathy of cigarette smoking.
Acta Neuropathologica, 2014, 127: 53-69.
5. World Health Organization focuses on antitobacco efforts in developing nations through
treaty. Brower VJ Natl Cancer Inst. 2006 May 17; 98(10):667-8.
6. Cheraghi M, Salvi S. Environmental tobacco smoke (ETS) and respiratory health in
children. Eur J Pediatr. 2009;168:897–905.
7. Seong MW, Hwang JH, Moon JS, Ryu HJ, Kong SY, Um TH, et al. Neonatal hair
nicotine levels and fetal exposure to paternal smoking at home. Am J Epidemiol.
2008;168:1140–1144.
8. Canfield RL, Jusko TA, Kordas K. Environmental lead exposure and children's cognitive
function. Riv Ital Pediatr. 2005;31(6):293–300.
9. Landrigan PJ, Carlson JE. Environmental policy and children's health. Future
Child. 1995;5:34–52.
10. Mannino DM, Moorman JE, Kingsley B, Rose D, Repace J. Health effects related to
environmental tobacco smoke exposure in children in the United States: data from the
Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc
Med. 2001;155:36–41.
11. Martinez FD, Morgan WJ, Wright AL, Holberg C, Taussig LM Group Health Medical
Associates. Initial airway function is a risk factor for recurrent wheezing respiratory
illnesses during the first three years of life. Am Rev Respir Dis. 1991;143:312–316.
12. Ginsberg G, Hattis D, Sonawane B, Russ A, Banati P, Kozlak M, et al. Evaluation of
child/adult pharmacokinetic differences from a database derived from the therapeutic
drug literature. Toxicol Sci. 2002;66:185–200.
13. Dempsey, D., Jacob, P., & Benowitz, N. L. Nicotine metabolism and elimination kinetics
in newborns. Clinical Pharmacology & Therapeutics, 2000; 67(5), 458-465.
14. Leong, J. W., Dore, N. D., Shelley, K., Holt, E. J., Laing, I. A., Palmer, L. J., & LeSouef,
P. N. The elimination half-life of urinary cotinine in children of tobacco-smoking
mothers. Pulmonary pharmacology & therapeutics, 1998; 11(4), 287-290.
15. Chilmonczyk BA, Salmun LM, Megathlin KN, Neveux LM, Palomaki GE, Knight GJ, et
al. Association between exposure to environmental tobacco smoke and exacerbations of
asthma in children [see comments] N Engl J Med. 1993;328:1665–1669.

16. Ehrlich RI, Du Toit D, Jordaan E, Zwarenstein M, Potter P, Volmink JA, et al. Risk
factors for childhood asthma and wheezing. Importance of maternal and household
smoking. Am J Respir Crit Care Med. 1996;154:681–688.
17. Martinez FD, Cline M, Burrows B. Increased incidence of asthma in child ren of smoking
mothers. Pediatrics. 1992;89:21–26.
18. Gergen PJ, Fowler JA, Maurer KR, Davis WW, Overpeck MD. The burden of
environmental tobacco smoke exposure on the respiratory health of children 2 months
through 5 years of age in the United States: Third National Health and Nutrition
Examination Survey, 1988 to 1994. Pediatrics. 1998;101:E8.
19. Martinez FD, Antognoni G, Macri F, Bonci E, Midulla F, De Castro G, Ronchetti R.
Parental smoking enhances bronchial responsiveness in nine-year-old children. Am Rev
Respir Dis. 1988;138:518–523.
20. Rylander E, Pershagen G, Eriksson M, Bermann G. Parental smoking, urinary cotinine,
and wheezing bronchitis in children. Epidemiology. 1995;6:289–293.
21. McMartin KI, Platt MS, Hackman R, Klein J, Smialek JE, Vigorito R, et al. Lung tissue
concentrations of nicotine in sudden infant death syndrome (SIDS) J
Pediatr. 2002;140:205–209
22. Wisborg K, Kesmodel U, Henriksen TB, Olsen SF, Secher NJ. A prospective study of
smoking during pregnancy and SIDS. Arch Dis Child. 2000;83:203–206.
23. Yeramaneni S, Dietrich KN, Yolton K, Parsons PJ, Aldous KM, Haynes EN. Secondhand
Tobacco Smoke Exposure and Neuromotor Function in Rural Children. J Pediatr.
2015;167(2):253–9.e1. doi:10.1016/j.jpeds.2015.03.014
24. Yolton K, Dietrich K, Auinger P, Lanphear BP, Hornung R. 2005. Exposure to
environmental tobacco smoke and cognitive abilities among U.S. children and
adolescents. Environ Health Perspect 113:98–103; doi:10.1289/ehp.7210.
25. Julvez, J., Ribas-Fitó, N., Torrent, M., Forns, M., Garcia-Esteban, R., & Sunyer, J.
Maternal smoking habits and cognitive development of children at age 4 years in a
population-based birth cohort. International Journal of Epidemiology, 2007; 36(4), 825832.
26. Lee, B. E., Hong, Y. C., Park, H., Ha, M., Kim, J. H., Chang, N., ... & Kim, Y. J. (2011).
Secondhand smoke exposure during pregnancy and infantile
neurodevelopment. Environmental research, 111(4), 539-544.
27. Benowitz NL, Jacob P III, Denaro C, et al. Stable isotope studies of nicotine kinetics and
bioavailability. Clin Pharmacol Ther 1991;49:270-7
28. Benowitz, N. L. Cotinine as a biomarker of environmental tobacco smoke
exposure. Epidemiologic reviews, 1996; 18(2), 188-204.
29. Moir, D., Rickert, W. S., Levasseur, G., Larose, Y., Maertens, R., White, P., &
Desjardins, S. A comparison of mainstream and sidestream marijuana and tobacco
cigarette smoke produced under two machine smoking conditions. Chemical research in
toxicology, 2007; 21(2), 494-502.
30. Neal, M. S., Hughes, E. G., Holloway, A. C., & Foster, W. G. Sidestream smoking is
equally as damaging as mainstream smoking on IVF outcomes. Human
reproduction, 2005; 20(9), 2531-2535.
31. Nelson PR, Heavner DL, Collie BB, et al. Effect of ventilation and sampling time on
environmental tobacco smoke component ratios. Environ Sci Technol 1992;26:1909-15.

32. Eatough DJ, Benner CL, Tang H, et al. The chemical composition of environmental
tobacco smoke. III. Identification of conservative tracers of environmental tobacco
smoke. Environ Int 1989;15:19-28.25.
33. Rando RJ, Menon PK, Poovey HG, et al. Assessment of multiple markers of
environmental tobacco smoke (ETS) in controlled, steady-state atmospheres in a dynamic
test chamber. Am Ind Hyg Assoc J 1992;53:699-704
34. Benowitz NL, Jacob P III, Fong I, et al. Nicotine metabolic profile in man: comparison
of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther 1994;268:296-303.
35. Respiratory health effects of passive smoking: lung cancer and other disorders.
Washington, DC: Office of Health and Environmental Assessment, Office of Research
and Development, US Environmental Protection Agency, 1992.
36. Eliopoulos, C., Klein, J., Phan, M. K., Knie, B., Greenwald, M., Chitayat, D., & Koren,
G. Hair concentrations of nicotine and cotinine in women and their newborn
infants. Jama, 1994; 271(8), 621-623.
37. Lewis BA, Minnes S, Min MO, et al. Blood lead levels and longitudinal language
outcomes in children from 4 to 12 years. J Commun Disord. 2018;71:85–96.
doi:10.1016/j.jcomdis.2018.01.001
38. ATSDR. Toxicological Profile for Lead. Atlanta, GA: U.S. Department of Health and
Human Services, Public Health Service, Agency for Toxic Substances and Disease
Registry; 1999.
39. Bellinger DC, Stiles KM, Needleman HL. Low-level lead exposure, intelligence and
academic achievement: a long-term follow-up study [see
comments] Pediatrics. 1992;90:855–61.
40. Schwartz J. Low-level lead exposure and children’s IQ: a meta-analysis and search for a
threshold. Environ Res. 1994;65:42–55.
41. Surkan PJ, Zhang A, Trachtenberg F, Daniel DB, McKinlay S, Bellinger DC.
Neuropsychological function in children with blood lead levels <10 microg/dL.
Neurotoxicology. 2007;28(6):1170-7
42. Liu J, Li L, Wang Y, Yan C, Liu X. Impact of low blood lead concentrations on IQ and
school performance in Chinese children. PLoS One. 2013;8(5):e65230. Published 2013
May 29. doi:10.1371/journal.pone.0065230
43. Seo J, Lee BK, Jin SU, et al. Lead-induced impairments in the neural processes related to
working memory function. PLoS One. 2014;9(8):e105308. Published 2014 Aug 20.
doi:10.1371/journal.pone.0105308
44. Khalil, N., Morrow, L. A., Needleman, H., Talbott, E. O., Wilson, J. W., & Cauley, J. A.
Association of cumulative lead and neurocognitive function in an occupational
cohort. Neuropsychology, 2009; 23(1), 10.
45. Stewart, W. F., & Schwartz, B. S. (2007). Effects of lead on the adult brain: A 15‐year
exploration. American Journal of Industrial Medicine, 50(10), 729-739.
46. Schwartz, B. S., Stewart, W. F., Bolla, K. I., Simon, D., Bandeen-Roche, K., Gordon, B.,
... & Todd, A. C. Past adult lead exposure is associated with longitudinal decline in
cognitive function. Neurology, 2000; 55(8), 1144-1150.
47. Aschner, J. L., & Aschner, M. Nutritional aspects of manganese homeostasis. Molecular
aspects of medicine, 2005; 26(4-5), 353-362.

48. Papavasiliou, P. S., S. T. Miller, and G. C. Cotzias. Role of liver in regulating distribution
and excretion of manganese. American Journal of Physiology-Legacy Content 211.1
(1966): 211-216.
49. Haynes, Erin N., Erin N., Heidi Sucharew, Pierce Kuhnell, Jody Alden, Mary Barnas,
Robert O. Wright, Patrick J. Parsons et al. Manganese exposure and neurocognitive
outcomes in rural school-age children: the communities actively researching exposure
study (Ohio, USA). Environmental health perspectives 123.10 (2015): 1066-1071.
50. Hernández-Bonilla D, Schilmann A, Montes S, Rodríguez-Agudelo Y, Rodríguez-Dozal
S, Solís- Vivanco R, et al. 2011. Environmental exposure to manganese and motor
function of children in Mexico. Neurotoxicology 32:615–621.
51. Long Z, Jiang YM, Li XR, Fadel W, Xu J, Yeh CL, et al. 2014. Vulnerability of welders
to manganese exposure—a neuroimaging study. Neurotoxicology 45:285–292.
52. Lucchini RG, Guazzetti S, Zoni S, Donna F, Peter S, Zacco A, et al. 2012. Tremor,
olfactory and motor changes in Italian adolescents exposed to historical ferro-manganese
emission. Neurotoxicology 33:687–696.
53. Claus Henn B, Ettinger AS, Schwartz J, Téllez-Rojo MM, Lamadrid-Figueroa H,
Hernández-Avila M, et al. 2010. Early postnatal blood manganese levels and children’s
neurodevelopment. Epidemiology 21:433–439.
54. Torres-Agustín, R., Rodríguez-Agudelo, Y., Schilmann, A., Solís-Vivanco, R., Montes,
S., Riojas-Rodríguez, H. & Ríos, C. Effect of environmental manganese exposure on
verbal learning and memory in Mexican children. Environmental research, 2013; 121,
39-44.
55. Wasserman, G. A., Liu, X., Parvez, F., Factor-Litvak, P., Kline, J., Siddique, A. B &
Balac, O. Child intelligence and reductions in water arsenic and manganese: a two-year
follow-up study in Bangladesh. Environmental health perspectives, 2014; 124(7), 11141120.
56. Oulhote, Y., Mergler, D., Barbeau, B., Bellinger, D. C., Bouffard, T., Brodeur, M. È. &
Bouchard, M. F. Neurobehavioral function in school-age children exposed to manganese
in drinking water. Environmental health perspectives, 2014; 122(12), 1343-1350.
57. Haynes EN, Beidler C, Wittberg R, Meloncon L, Parin M, Kopras EJ, et al. 2011.
Developing a bidi- rectional academic–community partnership with an AppalachianAmerican community for environ- mental health research and risk communication.
Environ Health Perspect 119:1364–1372; doi:10.1289/ ehp.1003164.
58. Rugless F, Bhattacharya A, Succop P, Dietrich KN, Cox C, Alden J, et al. 2014.
Childhood exposure to manga- nese and postural instability in children living near a
ferromanganese refinery in Southeastern Ohio. Neurotoxicol Teratol 41:71–79.
59. Bernert JT Jr, Turner WE, Pirkle JL, Sosnoff CS, Akins JR, Waldrep MK, et al. 1997.
Development and validation of sensitive method for determination of serum cotinine in
smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization
tandem mass spectrometry. Clin Chem 43:2281–2291.
60. Praamsma ML, Arnason JG, Parsons PJ. 2011. Monitoring Mn in whole blood and urine:
a comparison between electrothermal atomic absorption and inorganic mass
spectroscopy. J Anal At Spectrom 26:1224–1232.
61. Birdsall RE, Kiley MP, Segu ZM, Palmer CD, Madera M, Gump BB, et al. 2010. Effects
of lead and mercury on the blood proteome of children. J Proteome Res 9:4443–4453.
62. McKelvey W, Gwynn RC, Jeffrey N, Kass G, Thrope LE, Garg RK, et al. 2007. A

biomonitoring study of lead, cadmium, and mercury, in the blood of New York City
adults. Environ Health Perspect 115:1435–1441; doi:10.1289/ehp.10056.
63. Makin J, Fried PA, Watkinson B. A comparison of active and passive smoking during
pregnancy: long-term effects. Neurotoxicol Teratol 1991;13(1):5e12.
64. Bauman KE, Koch GG, Fisher LA. Family cigarette smoking and test performance by
adolescents. Health Psychology 1989;8(1):97e105
65. Breslau N, Paneth N, Lucia VC, Paneth-Pollak R. Maternal smoking during pregnancy
and offspring IQ. Int J Epidemiol 2005;34(5):1047e53.
66. Cho S-C, Kim B-N, Hong Y-C, Shin M-S, Yoo HJ, Kim J-W, et al. Effect of
environmental exposure to lead and tobacco smoke on inattentive and hyperactive
symptoms and neurocognitive performance in children. J Child Psychol Psychiatry
2010;51(9):1050e7.
67. LeeB-E,HongY-C,ParkH,KimJH,ChangN,RohY-M,etal.Secondhandsmoke exposure
during pregnancy and infantile neurodevelopment. Environ Res 2011;111(4):539e44.
http://dx.doi.org/10.1016/j.envres.2011.02.014
68. Heffernan, TM, O’Neill, TS. Exposure to second -hand smoke damages everyday
prospective memory. Society for the Study of Addiction. 2012.
69. Chen R, Wilson K, Chen Y, et al. Association between environmental tobacco smoke
exposure and dementia syndromes. Occup Environ Med. 2012;70(1):63–69.
doi:10.1136/oemed-2012-100785
70. Friedrich MJ. Researchers report new clues to dementia. JAMA. 2007 Jul 11;
298(2):161-3.
71. Rabbitt, P., Donlan, C., Watson, P., & McInnes, L. Unique and interactive effects of
depression, age, socioeconomic ad- vantage, and gender on cognitive performance of
normal healthy older people. Psychology and Aging, 1995; 10, 307–313.
72. Herlitz, A., Airaksinen, E., & Nordstroem, E. Sex differences in episodic memory: The
impact of verbal and visuospa- tial ability. Neuropsychology, 1990; 13, 590–597.
73. Kramer, J. H., Yaffe, K., Lengenfelder, J., & Delis, D. C. Age and gender interactions on
verbal memory performance. Journal of the International Neuropsychological
Society, 2007; 9(1), 97-102.
74. Kramer, J.H., Delis, D.C., Kaplan, E., O’Donnell, L., & Prifitera, A. (1997).
Developmental sex differences in verbal learning. Neuropsychology, 11, 577–584
75. Bellinger DC. What is an adverse effect? A possible resolution of clinical and
epidemiological perspectives on neurobehavioral toxicity. Environ Res 2004; 95: 394405.

CVLT-C Measures
Learning Slope

Exposed to SHS
-0.17 (-0.33, -0.01)

Not exposed to SHS
-0.11 (-0.27, 0.04)

p-value
0.63

Total Leaning
Short-delay recall
Immediate recall (List
B)
•
•

47.5 (46.2, 48.8)
-0.14 (-0.27, -0.01)
-0.31 (-0.44, -0.18)

50.7 (49.3, 52.2)
0.04 (-0.098, 0.17)
-0.15 (-0.29, -0.004)

0.001**
0.06
0.1

Z-scores for learning slope, short-delay recall and immediate recall of list B
T-scores for total learning

After Adding Lead into all models
Learning and
Memory Outcomes

Explanatory
Variables

β

P-value

Adjusted R2

Learning slope

Serum Cotinine
Lead

-0.015 (-0.073 to 0.04)
-0.11 (-0.35 to 0.13)

0.603
0.378

0.004

Total Learning

Serum Cotinine
Age at test
M vs F
Lead

-0.62 (-1.09 to -0.16)
0.162 (0.06 to 0.26)
-0.27 (-0.46 to -0.087)
0.105 (-0.09 to 0.303)

0.015
0.060
0.004
0.302

0.05

Short-Delay recall

Serum Cotinine
Age at test
M vs F
Lead

-0.076 (-0.12 to -0.03)
0.165 (0.064 to 0.27)
-0.269 (-0.45 to -0.08)
0.070 (-0.13 to 0.268)

0.0013
0.0014
0.0135
0.486

0.075

Immediate recall
(List B)

Serum Cotinine
Age at test
M vs F
Lead

-0.03 (-0.08 to -0.61)
0.14 (0.04 to 0.25)
0.10 (-0.50 to -0.11)

0.23
0.009
0.003

0.06

